GENinCode Plc (LON:GENI – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 0.90 and last traded at GBX 0.95, with a volume of 19445963 shares changing hands. The stock had previously closed at GBX 1.17.
GENinCode Stock Down 14.5%
The company has a debt-to-equity ratio of 7.17, a quick ratio of 15.89 and a current ratio of 2.80. The stock has a market cap of £7.25 million, a P/E ratio of -0.43 and a beta of 0.61. The stock’s fifty day simple moving average is GBX 1.13 and its 200-day simple moving average is GBX 1.55.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Stories
- Five stocks we like better than GENinCode
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
